Our findings may contribute to an improved understanding of the molecular mechanisms underlying skeletal development, as well as opportunities for the development of drugs targeting cartilage diseases associated with the abnormal expression or functioning of SOX9 in humans, such as campomelic dysplasia (Wagner et al., 1994). Here, SOX9 is linked to campomelic dysplasia.